Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle
E S
ES
Department of Surgery, University of Chicago, Illinois 60637.
Heffron
T G
TG
Stuart
J K
JK
Thistlethwaite
J R
JR
Stuart
F P
FP
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone